Patient characteristics of the nontransplantation control cohort (n = 432)
| . | Value . |
|---|---|
| Median age, y (range) | 51 (17-79) |
| Age | |
| 0-17 y, n (%) | 1 (0.2) |
| 18-30 y, n (%) | 54 (13) |
| 31-40 y, n (%) | 77 (18) |
| 41-50 y, n (%) | 84 (19) |
| 51-60 y, n (%) | 130 (30) |
| 61-80 y, n (%) | 102 (20) |
| Sex | |
| Male, n (%) | 235 (54) |
| Female, n (%) | 197 (46) |
| Cytogenetic risk | |
| Good, n (%) | 83 (19) |
| Intermediate, n (%) | 221 (51) |
| Poor, not MK, n (%) | 68 (156) |
| Poor, MK, n (%) | 22 (5) |
| Unknown, n (%) | 38 (9) |
| Status at reference date* | |
| Remission (in CR1), n (%) | 368 (85) |
| Relapse, n (%) | 64 (15) |
| . | Value . |
|---|---|
| Median age, y (range) | 51 (17-79) |
| Age | |
| 0-17 y, n (%) | 1 (0.2) |
| 18-30 y, n (%) | 54 (13) |
| 31-40 y, n (%) | 77 (18) |
| 41-50 y, n (%) | 84 (19) |
| 51-60 y, n (%) | 130 (30) |
| 61-80 y, n (%) | 102 (20) |
| Sex | |
| Male, n (%) | 235 (54) |
| Female, n (%) | 197 (46) |
| Cytogenetic risk | |
| Good, n (%) | 83 (19) |
| Intermediate, n (%) | 221 (51) |
| Poor, not MK, n (%) | 68 (156) |
| Poor, MK, n (%) | 22 (5) |
| Unknown, n (%) | 38 (9) |
| Status at reference date* | |
| Remission (in CR1), n (%) | 368 (85) |
| Relapse, n (%) | 64 (15) |
Reference date is 6 months after registration for SWOG studies.